The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $12.39

Today's change+1.62 +15.04%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $12.39

Today's change+1.62 +15.04%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.

Ehealth Inc Hits New 20-day High

Ehealth Inc closed up sharply Friday, rallying (U.S.)$1.62 or 15.04% to (U.S.)$12.39 and setting a new 20-day high. Over the last five days, shares have gained 11.02% and 16.34% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $10.35
  • Previous close(U.S.) $10.77
  • High(U.S.) $12.55
  • Low(U.S.) $10.35
  • Bid / Ask(U.S.) $8.00 / (U.S.) $14.50
  • YTD % change+16.34%
  • Volume542,235
  • Average volume (10-day)130,550
  • Average volume (1-month)107,923
  • Average volume (3-month)196,050
  • 52-week range(U.S.) $6.38 to (U.S.) $15.14
  • Beta1.62
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.26
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-2.61%

Ehealth Inc has a net profit margin of -2.61%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.57%Sector:FinancialsIndustry:Insurance - Multiline
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue44323774
Total other revenue--------
Total revenue44323774
Gross profit43323772
Total cost of revenue0012
Total operating expense61394350
Selling / general / administrative60394248
Research & development--------
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-17-7-624
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-17-7-624
Income after tax-17-6018
Income tax, total0-1-56
Net income-17-6018
Total adjustments to net income--------
Net income before extra. items-17-6018
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-17-6018
Inc. avail. to common incl. extra. items-17-6018
Diluted net income-17-6018
Dilution adjustment------0
Diluted weighted average shares18181818
Diluted EPS excluding extraordinary itemsvalue per share-0.91-0.31-0.030.99
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.91-0.32-0.030.99